Related Experiment Video
Updated: Jun 22, 2026

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays
Published on: February 24, 2023
Endonucleases induced TRAIL-insensitive apoptosis in ovarian carcinoma cells
Tessa M Geel1, Gregor Meiss, Bernardina T van der Gun
1Department of Pathology and Medical Biology, Groningen University Institute for Drug Exploration, University Medical Center Groningen, Hanzeplein 1, Groningen, The Netherlands.
Abstract:
TRAIL induced apoptosis of tumor cells is currently entering phase II clinical settings, despite the fact that not all tumor types are sensitive to TRAIL. TRAIL resistance in ovarian carcinomas can be caused by a blockade upstream of the caspase 3 signaling cascade. We explored the ability of restriction endonucleases to directly digest DNA in vivo, thereby circumventing the caspase cascade. For this purpose, we delivered enzymatically active endonucleases via the cationic amphiphilic lipid SAINT-18((R)):DOPE to both TRAIL-sensitive and insensitive ovarian carcinoma cells (OVCAR and SKOV-3, respectively). Functional nuclear localization after delivery of various endonucleases (BfiI, PvuII and NucA) was indicated by confocal microscopy and genomic cleavage analysis. For PvuII, analysis of mitochondrial damage demonstrated extensive apoptosis both in SKOV-3 and OVCAR. This study clearly demonstrates that cellular delivery of restriction endonucleases holds promise to serve as a novel therapeutic tool for the treatment of resistant ovarian carcinomas.
Insights
Restriction endonucleases offer a novel approach to induce apoptosis in ovarian cancer cells, bypassing TRAIL resistance mechanisms. This DNA-digesting enzyme delivery shows promise for treating resistant ovarian carcinomas.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) therapy is entering clinical trials but faces resistance in some cancer types.
- Ovarian carcinomas can exhibit TRAIL resistance due to blockades in the caspase 3 signaling pathway.
Purpose of the Study:
- To investigate the efficacy of restriction endonucleases in inducing apoptosis by directly digesting DNA.
- To circumvent caspase cascade-dependent apoptosis pathways in TRAIL-resistant ovarian cancer cells.
Main Methods:
- Delivery of active restriction endonucleases (BfiI, PvuII, NucA) using SAINT-18((R)):DOPE lipid nanoparticles.
- Assessment of nuclear localization via confocal microscopy and genomic cleavage analysis.
- Evaluation of apoptosis induction and mitochondrial damage.
Main Results:
- Successful delivery and nuclear localization of restriction endonucleases in both TRAIL-sensitive (OVCAR) and insensitive (SKOV-3) ovarian carcinoma cells.
- PvuII enzyme demonstrated significant induction of apoptosis and mitochondrial damage in both cell lines.
- Genomic cleavage analysis confirmed endonuclease activity within the cells.
Conclusions:
- Cellular delivery of restriction endonucleases is a viable strategy to induce apoptosis in ovarian cancer.
- This approach offers a potential therapeutic avenue for TRAIL-resistant ovarian carcinomas.
- Direct DNA digestion by endonucleases bypasses upstream resistance mechanisms.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Nucleotide Excision Repair
Apoptosis

